Please login to the form below

Not currently logged in
Email:
Password:

cervical cancer

This page shows the latest cervical cancer news and features for those working in and with pharma, biotech and healthcare.

Merck’s Keytruda improves outcomes for metastatic cervical cancer patients

Merck’s Keytruda improves outcomes for metastatic cervical cancer patients

Merck – known as MSD outside the US and Canada – has revealed positive results for its checkpoint inhibitor Keytruda in patients with persistent, recurrent or metastatic cervical cancer. ... In March, Sanofi and Regeneron revealed positive data for

Latest news

More from news
Approximately 11 fully matching, plus 150 partially matching documents found.

Latest Intelligence

  • Why digital is the solution to the healthcare crisis Why digital is the solution to the healthcare crisis

    Be it treatment for cancer, aches and pains, unusual lumps, headaches – the general malay that you would visit your doctor or hospital for consultation and treatment. ... For example, the Irish Times recently reported that nearly 90% of women have not

  • Surviving cancer: a new era for patients Surviving cancer: a new era for patients

    This treatment quickly became the ‘gold standard’ for women with metastatic breast cancer. ... a terminal disease, and more towards helping cancer patients manage their condition effectively.

  • 2019: CRISPR and therapeutic gene editing comes of age 2019: CRISPR and therapeutic gene editing comes of age

    hope was that - without the brake of PD-1 – the edited cells would attack and defeat the cancer. ... The approach is however also set to be tested as an in vivo therapy for cervical cancer caused by human papillomavirus (HPV) by researchers in China,

  • AI’s potential in the pharma life cycle AI’s potential in the pharma life cycle

    Proactive intervention. Already AI is being used to identify women whose Twitter posts indicate they may have increased risk of developing two relatively rare diseases: ovarian cancer and cervical cancer.

  • Immunisation politicised Immunisation politicised

    human papilloma virus (HPV), including strains that lead to cervical cancer. ... Practitioners were concerned that a hasty introduction of the vaccine would lead to lower participation rates in cervical cancer screening programmes using the pap smear test

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Merck appoints new senior vice president Merck appoints new senior vice president

    Radvanyi will focus on leading the discovery of oncology therapies that leverage the natural ability of the body's immune system to fight cancer, as well as identifying biomarkers with the ... indications including lung, cervical and breast cancer.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • 'Smear Word' campaign for Roche aims to break taboos and save lives

    Many young women do not turn up for appointments, which puts them at risk of early signs of cervical cancer being missed. ... message being that spending a few minutes having a smear test could save your life – with cervical cancer highly preventable

  • #DemandDiversity: Names erased from history: A dive into black history of clinical research #DemandDiversity: Names erased from history: A dive into black history of clinical research

    Henrietta Lacks. Henrietta was an African American woman, who was being treated for cervical cancer in the late 1940’s. ... After receiving radiation therapy, Henrietta was sent home. She sadly died from the same cancer a few years later in 1951.

  • The impact of COVID-19 on cancer care

    Cancer screening. The NHS offers bowel, breast and cervical cancer screening programmes to identify individuals at high risk of these cancers and to enable early diagnosis and treatment for those affected. ... that the diagnosis and management of

  • A new vision for tackling key illnesses

    The NHS will also implement HPV primary screening for cervical cancer across England by 2020. ... Cancer Alliances will also work with Integrated Care Systems (ICSs) to aid swift access to a consultant’s opinion.

  • Is our health at risk by delaying Dr appointments? Is our health at risk by delaying Dr appointments?

    2. It is understood that another contributory factor for the development of cervical cancer is smoking cigarettes. ... infections. Therefore, cutting down on smoking could help to reduce the risk of developing cervical cancer.

More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...